Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues $ 7,466,019 $ 3,515,815
Cost of revenues 2,597,917 1,254,790
Gross profit 4,868,102 2,261,025
Operating expenses:    
Personnel 1,513,383 673,375
Marketing and promotion 112,384 118,899
General and administrative 2,247,935 1,691,032
Total operating expenses 3,873,702 2,483,306
Operating income (loss) 994,400 (222,281)
Non-operating income (expenses):    
Interest expense (2,691,145) (1,940,547)
Interest income 46,031 282,409
Equity in earnings of investments 1,958,407
Change in fair value of investments (687,002)
Total non-operating income (expenses), net (3,332,116) 300,269
Net income (loss) (2,337,716) 77,988
Net income (loss) attributable to noncontrolling interests 83,728 101,199
Net income (loss) attributable to MariMed Inc. $ (2,421,444) $ (23,211)
Net loss per share $ (0.01) $ 0.00
Weighted average common shares outstanding 230,829,366 212,034,324